A missing or sloppy controlled substance inventory is one of the fastest ways to turn a routine board inspection into a formal investigation. The federal requirement — a complete count every two years — is the floor, not the whole picture. State law frequently layers on additional requirements, and the gap between “technically compliant with DEA” and “actually defensible in an audit” is where most citations happen.
The federal baseline: biennial inventory
Under the Controlled Substances Act, every DEA registrant must conduct a complete physical inventory of all controlled substances on hand at least once every two years. The inventory must include:
- The date and time of the count (beginning or close of business — this must be documented and consistent).
- Exact counts for Schedule II drugs, obtained by an actual physical count of every tablet, capsule, or unit — not an estimate.
- Estimated counts are permitted for Schedule III-V substances, unless the container holds more than 1,000 units, in which case an exact count is required.
- The name, strength, and dosage form of each drug, along with the number of units or volume in each container.
The inventory must be kept on file for a minimum of two years at the registered location and made readily retrievable for inspection. Most pharmacies choose to conduct their biennial count on the same date each cycle (often the anniversary of DEA registration or a fixed calendar date like May 1) to keep the recordkeeping simple, though the statute doesn’t mandate a specific date.
Where state law adds requirements
DEA sets the floor; state boards frequently require more, and this is where pharmacies operating across multiple states run into trouble treating “DEA compliant” as synonymous with “fully compliant.”
- More frequent counts — Several states require annual rather than biennial inventory of Schedule II substances, or require a full count at any change of pharmacist-in-charge, not just on a fixed calendar cycle.
- Perpetual inventory for Schedule II — A growing number of states require a running, continuously updated perpetual inventory for Schedule II drugs (updated with every receipt and every dispensing transaction), which is a meaningfully higher bar than a periodic physical count.
- Change of PIC counts — Many state boards independently require a physical inventory whenever the pharmacist-in-charge changes, regardless of where that falls in the DEA’s two-year cycle.
- Reconciliation against ordering records — State inspectors frequently check that inventory counts reconcile against DEA Form 222 records (or the CSOS electronic equivalent) for Schedule II purchases and against invoices for Schedule III-V, looking for unexplained gaps.
Why discrepancies happen and how they get caught
Most discrepancies aren’t theft — they’re transcription errors, unreconciled returns-to-stock, or a count that didn’t happen on the date the paperwork says it did. Inspectors and PBM auditors both look for the same red flags: a biennial inventory date that doesn’t match employment records for who was on duty, counts that don’t reconcile against ordering volume, and gaps between when a drug was received (per invoice or 222 form) and when it shows up in the inventory log. If you’re navigating an audit that turned up inventory discrepancies alongside claims issues, our guide to the pharmacy audit appeal process covers how to respond before recoupment or board referral becomes final.
Recordkeeping retention and format
DEA requires controlled substance records — inventories, order forms, dispensing logs — to be maintained for a minimum of two years, though several states require three years or longer, so retention policy should be set to your strictest applicable requirement, not the federal minimum. Schedule II records generally must be kept separate and readily retrievable from other prescription records; many states also require Schedule III-V records to be either separate or readily retrievable through some other clear method, such as a red flag or stamp on the hard-copy record. Electronic inventory systems are acceptable in most states as long as they’re auditable, backed up, and can produce the required inventory data on demand during an inspection.
Practical steps to stay audit-ready
- Confirm whether your state requires more frequent counts or perpetual inventory for Schedule II drugs — don’t assume the DEA’s two-year cycle is sufficient everywhere you’re licensed.
- Reconcile inventory against DEA 222 forms (or CSOS records) and invoices at least quarterly, not just at the biennial count, so discrepancies get caught while they’re still explainable.
- Conduct and document a full physical inventory any time the pharmacist-in-charge changes, even in states where it isn’t explicitly mandated — it protects the outgoing and incoming PIC alike.
- Store inventory records in a format that’s instantly retrievable, since inspectors typically expect production within a short window during an on-site visit.
This is a general overview of common federal and state inventory requirements; exact counting frequency, retention periods, and format rules vary by state and can change, so verify current requirements with your state board of pharmacy and the DEA before your next inventory cycle. Pharmacists managing Schedule II-V compliance across multiple states should also review our guide on gabapentin scheduling by state and tramadol and xylazine state scheduling, since inventory obligations extend to any substance a state has independently scheduled beyond the federal list.
RxByState tracks controlled substance inventory rules, retention periods, and Schedule II-V scheduling differences across all 50 states. Start a free 14-day trial →